Cambridge, MA, United States of America

Nagesh K Mahanthappa

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 3.2

ph-index = 10

Forward Citations = 315(Granted Patents)


Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Nagesh K Mahanthappa: Innovator in Antibody and Growth Factor Development

Introduction

Nagesh K Mahanthappa is a prominent inventor based in Cambridge, MA, recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 18 patents, he has dedicated his career to advancing medical science through innovative research and development focused on antibodies and growth factors.

Latest Patents

Mahanthappa’s latest patents showcase his cutting-edge work in biotechnology. One such patent is titled "Compositions for making and using anti-Myostatin antibodies." This patent describes antibodies that specifically bind to proMyostatin and/or latent Myostatin, along with their various uses. Another noteworthy patent, "Compositions and methods for growth factor modulation," provides insights into proteins, antibodies, assays, and methods that can modulate growth factor levels and activities. These growth factors are crucial members of the TGF-β superfamily of proteins, influencing numerous biological processes.

Career Highlights

Throughout his career, Mahanthappa has held key positions at several leading biotechnology companies. He has worked at Scholar Rock, Inc., where he contributed to the development of innovative therapeutic solutions. Additionally, his tenure at Curis, Inc. further solidified his reputation as a pioneer in the field.

Collaborations

Nagesh has collaborated with several notable coworkers, including Michelle Marie Straub and Thomas Schurpf. These partnerships have allowed him to leverage collective expertise, driving forward innovative solutions in biotechnology.

Conclusion

With 18 patents to his name, Nagesh K Mahanthappa continues to make significant strides in biotechnology. His latest work on anti-Myostatin antibodies and growth factor modulation reflects his commitment to enhancing understanding and treatment options in medical science. As an inventor, his contributions are invaluable, paving the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…